IFNG and cancer: Generally, circulating lymphocytes modulate tumor growth and improve the survival rates of cancer patients through the production of cytokines (IFN-γ and TNF-α), and thus reduced quantity or exhaustion of lymphocytes impairs immune surveillance and defense in cancer (24, 25).